{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Cefodizime  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefodizime. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefodizime  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "cefodizime",
    "trial_2_text": "Cefodizime  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Cefodizime Supplement: 60 participants will take Cefodizime 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefodizime. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefodizime  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2517009675502777,
      "78": 0.2504766583442688,
      "177": 0.19665399193763733,
      "123": 0.18540410697460175,
      "17": 0.15724563598632812,
      "9": 0.15346835553646088,
      "20": 0.14775370061397552,
      "173": 0.14358283579349518,
      "21": 0.13666385412216187,
      "37": 0.13601860404014587,
      "14": 0.13491015136241913,
      "189": 0.1308615356683731,
      "46": 0.12938334047794342,
      "68": 0.1255171298980713,
      "188": 0.12295790016651154,
      "49": 0.1210293173789978,
      "79": 0.11232515424489975,
      "2": 0.11141116172075272,
      "350": 0.11026737093925476,
      "77": 0.10820595920085907,
      "200": 0.10316388309001923,
      "228": 0.10060106217861176,
      "67": 0.0987708643078804,
      "114": 0.0950675755739212,
      "76": 0.09506183862686157,
      "29": 0.09371741861104965,
      "180": 0.09158121049404144,
      "64": 0.08937237411737442,
      "243": 0.08485233783721924,
      "193": 0.0831705629825592,
      "61": 0.08279703557491302,
      "27": 0.08167709410190582,
      "126": 0.08118238300085068,
      "5": 0.08085270971059799,
      "86": 0.07696080207824707,
      "85": 0.07661908864974976,
      "72": 0.07619906216859818,
      "30": 0.0752662643790245,
      "179": 0.0749485045671463,
      "104": 0.07470012456178665,
      "28": 0.0722847506403923,
      "239": 0.07196731120347977,
      "276": 0.06875681132078171,
      "147": 0.06808269023895264,
      "101": 0.06805313378572464,
      "151": 0.06352873146533966,
      "131": 0.0634460523724556,
      "194": 0.061870425939559937,
      "35": 0.059277262538671494,
      "102": 0.05920974910259247,
      "116": 0.058806098997592926,
      "282": 0.05800768360495567,
      "269": 0.057203590869903564,
      "261": 0.05703231692314148,
      "139": 0.05672797933220863,
      "144": 0.056286852806806564,
      "18": 0.056068163365125656,
      "82": 0.05606269836425781,
      "122": 0.05507922172546387,
      "69": 0.05338059365749359,
      "396": 0.052781399339437485,
      "355": 0.05129905045032501,
      "249": 0.05070894584059715,
      "253": 0.05058399215340614,
      "132": 0.050006210803985596,
      "191": 0.049924153834581375,
      "186": 0.048186030238866806,
      "234": 0.047657497227191925,
      "38": 0.04670992121100426,
      "164": 0.04669307917356491,
      "96": 0.046173159033060074,
      "204": 0.04611163213849068,
      "262": 0.045921772718429565,
      "441": 0.045100137591362,
      "288": 0.044880516827106476,
      "92": 0.04458476975560188,
      "221": 0.04232950136065483,
      "1": 0.042157549411058426,
      "130": 0.04192005470395088,
      "466": 0.041787758469581604,
      "508": 0.041606537997722626,
      "75": 0.04053807631134987,
      "97": 0.03995372727513313,
      "494": 0.03914884850382805,
      "36": 0.039116378873586655,
      "100": 0.03880390152335167,
      "212": 0.03861267492175102,
      "341": 0.03840693086385727,
      "361": 0.03775035962462425,
      "286": 0.03702893853187561,
      "142": 0.03688898682594299,
      "268": 0.03640594333410263,
      "400": 0.036288656294345856,
      "256": 0.036174990236759186,
      "153": 0.03573310747742653,
      "4": 0.035720095038414,
      "31": 0.03531744331121445,
      "211": 0.03505904600024223,
      "98": 0.034791313111782074,
      "166": 0.03464687243103981
    },
    "trial_2_ae": {
      "87": 0.2517009675502777,
      "78": 0.2504766583442688,
      "177": 0.19665399193763733,
      "123": 0.18540410697460175,
      "17": 0.15724563598632812,
      "9": 0.15346835553646088,
      "20": 0.14775370061397552,
      "173": 0.14358283579349518,
      "21": 0.13666385412216187,
      "37": 0.13601860404014587,
      "14": 0.13491015136241913,
      "189": 0.1308615356683731,
      "46": 0.12938334047794342,
      "68": 0.1255171298980713,
      "188": 0.12295790016651154,
      "49": 0.1210293173789978,
      "79": 0.11232515424489975,
      "2": 0.11141116172075272,
      "350": 0.11026737093925476,
      "77": 0.10820595920085907,
      "200": 0.10316388309001923,
      "228": 0.10060106217861176,
      "67": 0.0987708643078804,
      "114": 0.0950675755739212,
      "76": 0.09506183862686157,
      "29": 0.09371741861104965,
      "180": 0.09158121049404144,
      "64": 0.08937237411737442,
      "243": 0.08485233783721924,
      "193": 0.0831705629825592,
      "61": 0.08279703557491302,
      "27": 0.08167709410190582,
      "126": 0.08118238300085068,
      "5": 0.08085270971059799,
      "86": 0.07696080207824707,
      "85": 0.07661908864974976,
      "72": 0.07619906216859818,
      "30": 0.0752662643790245,
      "179": 0.0749485045671463,
      "104": 0.07470012456178665,
      "28": 0.0722847506403923,
      "239": 0.07196731120347977,
      "276": 0.06875681132078171,
      "147": 0.06808269023895264,
      "101": 0.06805313378572464,
      "151": 0.06352873146533966,
      "131": 0.0634460523724556,
      "194": 0.061870425939559937,
      "35": 0.059277262538671494,
      "102": 0.05920974910259247,
      "116": 0.058806098997592926,
      "282": 0.05800768360495567,
      "269": 0.057203590869903564,
      "261": 0.05703231692314148,
      "139": 0.05672797933220863,
      "144": 0.056286852806806564,
      "18": 0.056068163365125656,
      "82": 0.05606269836425781,
      "122": 0.05507922172546387,
      "69": 0.05338059365749359,
      "396": 0.052781399339437485,
      "355": 0.05129905045032501,
      "249": 0.05070894584059715,
      "253": 0.05058399215340614,
      "132": 0.050006210803985596,
      "191": 0.049924153834581375,
      "186": 0.048186030238866806,
      "234": 0.047657497227191925,
      "38": 0.04670992121100426,
      "164": 0.04669307917356491,
      "96": 0.046173159033060074,
      "204": 0.04611163213849068,
      "262": 0.045921772718429565,
      "441": 0.045100137591362,
      "288": 0.044880516827106476,
      "92": 0.04458476975560188,
      "221": 0.04232950136065483,
      "1": 0.042157549411058426,
      "130": 0.04192005470395088,
      "466": 0.041787758469581604,
      "508": 0.041606537997722626,
      "75": 0.04053807631134987,
      "97": 0.03995372727513313,
      "494": 0.03914884850382805,
      "36": 0.039116378873586655,
      "100": 0.03880390152335167,
      "212": 0.03861267492175102,
      "341": 0.03840693086385727,
      "361": 0.03775035962462425,
      "286": 0.03702893853187561,
      "142": 0.03688898682594299,
      "268": 0.03640594333410263,
      "400": 0.036288656294345856,
      "256": 0.036174990236759186,
      "153": 0.03573310747742653,
      "4": 0.035720095038414,
      "31": 0.03531744331121445,
      "211": 0.03505904600024223,
      "98": 0.034791313111782074,
      "166": 0.03464687243103981
    }
  },
  "safety": {
    "trial_1_safety": 0.34326228499412537,
    "trial_2_safety": 0.34326228499412537
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4795033037662506
  }
}